Organ-on-a-chip developer Emulate said today it won a research grant to use its human Brain-Chip system to develop a research platform to be sent to the International Space Station. The company’s Brain-Chip consists of neuronal and vascular endothelial cells in a micro-engineered environment, and experiments will be conducted under healthy and inflamed states to assess […]
Emulate Inc
ATS Roundup: Emulate models viral infection in “asthma-on-a-chip”
Emulate‘s small airway-lung chip could help researchers study viral-induced exacerbations of asthma, according to data presented this week at the American Thoracic Society’s annual meeting. The studies were conducted as part of the company’s partnership with (NYSE:MRK). The collaborative project was designed to enable development of new anti-inflammatory treatments for patients with asthma, according to Emulate. […]
Emulate, LabCorp’s Covance launch organ-on-a-chip program
Emulate, Inc. and LabCorp‘s (NYSE:LH) Covance Drug Development biz inked a deal to collaborate for an organ-on-a-chip preclinical drug evaluation and testing service. Emulate’s organ-on-a-chip tech is designed to be a predictive model of the human body’s response to diseases and medications. The companies plan to combine the organ modeling tech with Covance’s expertise of drug […]
Organ-on-chip dev Emulate raises $29m
Boston-based biotech developer Emulate Inc. said yesterday it raised $28.7 million in a Series B round of financing looking to boost its organ-on-chip technology, and looks to bring in another $16.3 million before the round closes. The company is developing organ-on-chip technologies, which “places living human cells in micro-engineered environments” to provide insight into the […]